Understanding how nanoparticles can overcome biological barriers in medicine
Probing nano/bio interactions to understand and overcome biological barriers limiting nanomedicine
This study is looking at tiny particles that can help deliver medicine more effectively to treat diseases, making it easier for doctors to target the right cells and improve patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11101263 on NIH RePORTER |
What this research studies
This research focuses on engineering nanoparticles with special properties to improve the treatment of various diseases. By studying how these nanoparticles interact with biological systems, the team aims to enhance their ability to deliver therapies directly to affected cells. The approach includes using nanoparticles to deliver antibodies or nucleic acids that can inhibit disease progression, as well as utilizing light to activate treatments specifically in diseased tissues. The research also explores how the design and packaging of these nanoparticles influence their effectiveness in overcoming biological barriers.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with aggressive cancers, blood disorders, or maternal/fetal health conditions.
Not a fit: Patients with conditions that do not involve the biological barriers targeted by this research may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for aggressive cancers and blood disorders.
How similar studies have performed: Previous research has shown promise in using nanoparticles for targeted drug delivery, indicating potential success for this approach.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Day, Emily S — University of Delaware
- Study coordinator: Day, Emily S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.